ECHO DOWNEY: Open Payments
NPI 1881296515 · GILLETTE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 27 payments from 8 companies in 2025. Trend: 2023 $265 · 2024 $578 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $147 |
| Lundbeck LLC | 6 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| Alkermes, Inc. | 3 | $65 |
| Supernus Pharmaceuticals, Inc. | 1 | $38 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $17 |
Products named: REXULTI, CAPLYTA, ARISTADA, Qelbree, ABILIFY ASIMTUFII, UZEDY, Jornay PM, VRAYLAR.
Industry payments across WY — which companies pay providers there.
